- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Gufic Biosciences delivered strong Q1 FY27 results, with revenue at INR 260.8 Cr and PAT at INR 22.46 Cr, boosting EBITDA margin to 18.09%. The Indore plant is on track, with new depot and microsphere suites nearing completion and EU certification anticipated within 1-2 months. The company is strategically expanding...